హాడ్కిన్ లింఫోమా

The main aim of this study is to check how safe brentuximab vedotin is in adults with untreated Hodgkin Lymphoma (HL) when given together with doxorubicin (Adriamycin), vinblastine and dacarbazine therapy ('AVD'). Another aim is to learn how well treatment of brentuximab vedotin plus AVD works. All participants will receive brentuximab vedotin plus AVD for approximately 6 months. Participants will undergo tests like Echocardiography (ECHO) and pulmonary function testing (PFT) during the study. ECHO is a test that uses ultrasound to show how the heart muscle and valves are working; PFT is a te…

స్పాన్సర్: టకేడా
ClinicalTrials.gov లో NCT06831370
రిజిస్ట్రీలో చివరిసారిగా 23 Feb 2026 న అప్‌డేట్ చేయబడింది · మేము 20 Oct 2026 న చదివాము